Menu

Top Stories

Published on Friday, March 2, 2018

Celebrating Women: Alpha-1 Mom shares son’s transplant journey

Celebrating Women: Alpha-1 Mom shares son’s transplant journey

During Women's History Month, we are featuring the stories of women who help make the Alpha-1 community great.

Jude’s journey began at 4 weeks of age when, following seizures and emergency brain surgery, he was diagnosed with a vitamin K deficiency and began receiving treatment for this at his home in Coral Springs, Fla. Later, when he began to have liver issues, his physicians assumed it was a residual issue related to the vitamin K deficiency and would improve over time.

Julie and Jude Ward while they were waiting for his transplant

“I was on an online vitamin K deficiency support group and posted my concerns about Jude’s liver,” explains his mom, Nicole Ward. “Another mom on that group suggested we get Jude tested for Alpha–1.”

After Jude tested positive for Alpha–1, his physician reassured Nicole that “most Alpha–1 kids are fine.”

“At the time, I didn’t think much about it,” Nicole says. “I actually thought then, ’how much worse can it get?”

Unfortunately, things got a lot worse for Jude. In December of 2016, after his stomach swelled like a balloon, he was diagnosed with Stage 3/4 cirrhosis of the liver and Nicole and her husband Josef were told he would need a transplant.

In March of 2017, Jude and Nicole traveled to Children’s Hospital of Philadelphia (CHOP) to begin the evaluation process to be placed on the transplant list. What should have been a short transplant evaluation trip, turned into several weeks with Jude in and out of the hospital, living at the nearby CHOP “Gift of Life” house for transplant families in between hospital stays.

Just after his 2nd birthday in April, Jude was officially put on the liver transplant list with CHOP. At that same time, Jude’s dad, Josef, who is in the Airforce, secured a transfer from Florida to McGuire Airforce Base in New Jersey, not far from CHOP. In May, Josef officially moved the family to New Jersey to begin their long, hopeful wait.

After one false hope in early July - a liver was available, but then determined not to be the right size for Jude - the Wards continued their “new normal,” waiting for the call that would change Jude’s life forever. Like Finn’s family, they also hoped for a living donor. But ultimately that would not be the case.

On July 19, during a particularly difficult hospital stay for yet another bout of pancreatitis, they received the message they were so desperately hoping to hear: a liver was available for Jude.

“Jude’s donor was a 3-year-old,” explains Nicole. “I am so overwhelmed with this little one’s family and am carrying them with me like their child is my own now. I hope they will find comfort one day in knowing that we will cherish their decision to donate life forever.”

Jude was discharged on August 3 and continues to recover post-transplant at home with big brother Josiah, 4, by his side.

“We are forever grateful and will think of Jude’s hero and their family every day we look at him,” says Nicole.

“Register to be an organ donor, educate yourself on what that means and don’t let the common misconceptions deter you.”

This story first appeared in the Fall 2017 issue of Alpha–1-To-One Magazine. Subscriptions are free.

Follow the Ward family's journey on Facebook.


Print

Kathy Haduck receives Helen Chase Walsh Memorial Award

Thursday, June 17, 2010
AlphaNet Coordinator Kathy Haduck of Blandburg, PA, was honored with the Helen Chase Walsh Memorial Award at the recent annual education conference of the Alpha-1 Association in Orlando, FL. The award is presented each year by the Walsh family to...
Divider

Do you have the scoop on Alpha-1?

Thursday, June 17, 2010
Darin and Megan Chittick know exactly why it’s important to support Alpha-1 fundraisers. Their daughter, McKinley Chittick, who is now three years old, was diagnosed with Alpha-1 when she was just a month old. She developed severe jaundice...
Divider

$1 million donation by Cadwgans to help Alpha-1 Foundation "find new therapies and ultimately, a cure"

Wednesday, June 16, 2010
Ruth and Gordon E. Cadwgan, Jr., made a surprise announcement at this past weekend’s national education conference in Orlando: the donation of a million dollars to the Alpha-1 Foundation from themselves and Gordon Cadwgan, Sr. Gordon...
Divider

Foundation scientific director receives "outstanding investigator" award from Hungarian Respiratory Society

Wednesday, June 16, 2010
SOPRON, HUNGARY—Alpha-1 Foundation Scientific Director Adam Wanner, MD, recently received the “Outstanding Investigator Award” from the Hungarian Respiratory Society at its biennial meeting. Wanner gave the keynote speech at the...
Divider

Foundation presents Building Friends for a Cure awards

Monday, June 14, 2010
ORLANDO, FL—The Alpha-1 Foundation presented its Building Friends for a Cure awards Friday evening during the Alpha-1 Association’s annual educational conference. The Alpha-1 Foundation presented awards to the following. All-Star...
Divider

Alpha-1 protein to be tested as treatment for Type 1 diabetes

Wednesday, June 9, 2010
MarketWire DENVER, CO—Omni Bio Pharmaceutical, Inc. announced that the Barbara Davis Center for Childhood Diabetes has received regulatory clearance from the U.S. Food and Drug Administration (FDA) to initiate a Phase I and II clinical...
Divider

Childhood liver disease studies enrolling patients; some travel funds available to eligible families

Tuesday, June 8, 2010
The Childhood Liver Disease Research and Education Network (ChiLDREN) is enrolling children now for vital research studies on cholestatic liver diseases of children. In cholestatic liver disease, the flow of bile from the liver into the digestive...
Divider

Grifols, Talecris press release on planned acquisition

Monday, June 7, 2010
PR Newswire BARCELONA, Spain and RESEARCH TRIANGLE PARK, NC—Grifols a global healthcare company and leading producer of plasma protein therapies, and Talecris, a US-based biotherapeutics products company, today announced that they have...
Divider

Spanish company Grifols to acquire Talecris for $3.4 billion

Monday, June 7, 2010
Reuters Spain’s Grifols has agreed to buy US-based Talecris Biotherapeutics, which makes plasma-based protein therapies, for $3.4 billion in a bold move to expand its business in blood products. Talecris is the manufacturer of Prolastin,...
Divider

Marta Strock dies; one of first AlphaNet coordinators

Monday, June 7, 2010
Marta Strock was one of the first AlphaNet coordinators, and proud of it. “As an AlphaNet coordinator,” she told a magazine writer in 2004, “I have the opportunity to bring a wealth of knowledge about our disease to many Alphas...
Divider

Anti-seizure drug improves liver disease in Alpha-1 mice

Friday, June 4, 2010
A note from Robert A. Sandhaus, MD, PhD, clinical director of the Alpha-1 Foundation and medical director of AlphaNet: In the interest of presenting the latest information to our Alpha-1 community, the following press release has been posted...
Divider

Whom to test, whom to treat, for Alpha-1?

Friday, June 4, 2010
An examination of the current issues in testing and treating for Alpha-1 has been published by Robert A. Sandhaus, MD, PhD, in the journal Seminars in Respiratory and Critical Care Medicine. Sandhaus is clinical director of the Alpha-1...
Divider
First62636465666768697071

Article Search

Enter keywords in text box and click Search button for results.

Archive